Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variantKirsten E. Lyke, Anna Wald, Daniel Szydlo et al.|Cell Reports Medicine|2022Cited by 168
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boostNoemia S. Lima, Anna P. Wald, Lauren McCormick et al.|Science Translational Medicine|2026Cited by 0